Benralizumab efficacy by atopy status and serum immunoglobulin E for patients with severe, uncontrolled asthma

Benralizumab treatment decreased exacerbations and improved lung function for patients with severe, uncontrolled eosinophilic asthma regardless of serum IgE concentrations and atopy status.